24/7 Customer Support
The Poland Aesthetic Injectables Market is estimated to witness a growth of US$ 14.42 Million during 2022-2030 and is estimated to reach US$ 30.65 Million by 2030, registering a CAGR of 8.3% during the forecast period. Market growth is attributed to factors such as increasing awareness among people about wellness, health, and beauty, the rising market for cosmetic surgeries, and an increase in the number of certified dermatologists in the country. Moreover, technological advancements are also playing a major role in the development of the market as the demand for modern non-surgical methods has surpassed that for traditional ones in recent times.
The cumulative market share of key players in the market is around 42.9%. Some of the top players in the market are Allergan, Galderma Laboratories, L.P., Fotona D.O.O, and Merz Aesthetics. Market players are adopting strategies like mergers, acquisitions, and new product launches to stay competitive in the market.
To Get more Insights, Request A Free Sample
The merging of Poland in the EU has favored the growth of the EU cosmetic market. As the government focuses on improving the trade relations with the region and developing advanced healthcare systems in Poland, the demand for cosmetic procedures is expected to increase in Poland. The rising awareness among the population about their physical appearance, wellness, and health, and the subsequent increase in spending on cosmetics and beauty procedures, is also expected to favor market growth. Modern biochemical, chemical, and medical solutions are helping offer safer and more efficient plastic surgeries, driving the demand for modern cosmetic techniques.
The medical tourism sector has been growing at a significant pace in Poland over the past few years, leading to a notable increase in the number of medical procedures performed. Poland has been attracting more than 600 thousand medical tourists till now from the Baltic and Eastern European regions. The low cost of cosmetic treatments is one of the key factors contributing to the increasing footfall of medical tourists in Poland; the cost of medical procedures is almost one-third of other European countries. The government is also increasing the spending on healthcare and plans to take it to nearly 6% of the country’s GDP gradually by the estimate till 2028.
Dermal fillers are the most popular and nonsurgical injectable aesthetic procedures and are mainly used to address soft tissue abnormalities of the face. Dermal fillers based on Hyaluronic Acid (HA) are often used for aesthetic operations such as nasolabial folds, eye wrinkles, dark circles, scar repair, and rejuvenation. Moreover, hyaluronic acid injections are simple to use, effective, and relatively inexpensive.
HA fillers are shorter acting than biostimulators but are fully reversible with an injection of hyaluronidase, which neutralizes hyaluronic acid. Full results appear within days. As a result, the demand for HA injections has increased significantly in recent years and is expected to rise over the forecast period as well. The demand for biostimulators is also growing and is expected to grow at a higher CAGR than HA, at 9.1% over the forecast period.
Poland faces a lack of healthcare service providers, leaving a relatively high percentage of the Polish population with unmet medical needs. Access to health care is further hampered by high out-of-pocket spending, a shortage of healthcare professionals, and a relatively high number of uninsured people. The lack of beauty clinics with skilled doctors and medical staff also negatively impacts the number of cosmetic procedures and injectables procedures performed in Poland per year. However, the government is taking progressive steps to educate more surgeons and strengthen the healthcare facilities in Poland, which could help the market grow in the future.
The COVID-19 pandemic negatively impacted the Poland aesthetic injectables market as fewer people underwent cosmetic and plastic surgeries. The government-imposed restrictions during covid outbreak, lockdowns, and the fear of contracting the virus in public places dampened public enthusiasm for undergoing cosmetics treatments. This, in turn, reduced the number of visitors and patients in many cosmetic clinics, dermatology clinics, and hospitals. Many people canceled their appointments and sought to stay away from crowded places. The pandemic disrupted the industry's rate of innovation, revenue, and popularity in Poland. Moreover, beauty salons and beauty clinics were closed due to strict lockdown orders from the government.
Based on product type, the hyaluronic acid fillers segment held the highest share of 74.2% in 2021. Hyaluronic acid is widely used in the treatment of the signs of ageing and shows immediate results. Injectable HA is widely used to reduce the appearance of fine lines, facial folds, and wrinkles and to create structure, framework, and add volume to the face and lips.
In terms of route of administration, the subcutaneous segment is expected to register the highest CAGR of 8.9% over the forecast period. The segment also held the largest share of 53.5% in 2021 and is expected to retain dominance with a net increase of 2.9% by the end of the forecast period. This can be attributed to the higher demand for subcutaneous skincare treatments as a short needle is used to inject the drug into the tissue layer between the skin and the muscle. The injectables are injected to produce results directly only on the skin and can start showing results within a week.
To Understand More About this Research: Request A Free Sample
In terms of application, the wrinkle reduction segment held the highest market share of 24.1% in 2021. This can be attributed to the increasing demand for wrinkle reduction injectables from men and women worldwide. Wrinkles are often the first signs of ageing and are among the most common skin-related concerns among middle-aged people. The rising expenditure of an increasing number of people across the globe on aesthetic treatments for wrinkle reduction is expected to drive the segment.
In terms of packaging type, the vials segment is expected to register the highest CAGR of 9.2% over the forecast period. Vials have been chiefly used for pharmaceutical packaging for many years and maintain a strong position in the industry. The segment is followed by the syringes and ampules segments, which are expected to register CAGRs of 8% and 6.9%, respectively, over the forecast period.
Based on end user, the dermatology clinics segment holds the dominant position in the market, followed by hospitals and others. The dermatology clinics segment is expected to be valued at US$ 20.23 million in 2030 from US$ 10.13 million in 2021. The segment is also expected to register the highest CAGR of 8.7% over the forecast period. The preference of patients for dermatology clinics for cosmetic services is increasing gradually year on year because clinics offer a variety of services. Cosmetic dermatology is skin, hair, or body treatment designed to improve a patient's appearance and the dermatologist focuses on improving appearance rather than curing a disease.
Based on distribution channel, the hospitals segment dominated the Poland aesthetic injectables market in terms of having the highest market share of 70.1% and Online Pharmacies having the highest CAGR of 9.7% followed by Retail Stores and then Hospital.
The Poland aesthetic injectables market is segmented into:
By Product Type
By Route of Administration
By Packaging Type
By End User
By Distribution Channel
Aesthetic injectables dermal fillers are medications that help with face rejuvenation which helps in the treatment of early signs of ageing or add benefit to a facial rejuvenation process. They are also known as Derma Fillers.
The demand for Aesthetic Injectables is rising due to increasing concern of people for their physical appearance, wellness, and health.
A thread lift is a treatment in which the skin is lifted gradually using temporary sutures and they are more popular than surgical procedures due to the increasing need for non-surgical operations.
The Poland Aesthetic Injectables Market is estimated to reach US$ 30.65 Million by the end of 2030 from US$ 15.87 Million in 2021.
The rising market in EU and increase in the medical tourism in Poland are the major driving factors for Poland Aesthetic Injectables Market.
The Wrinkle Reduction segment has the highest CAGR of 10.1% in the Poland Aesthetic Injectables Market.
The Booming demand for Dermal fillers and Hyaluronic acid injections as they are simple to use, effective, and relatively inexpensive.
The main users of the market are Hospitals, Dermatology Clinics, and Others.
The Lack of enough dermatologist and cosmetic surgeons and The lack of enough beauty clinics with skilled doctors and medical staff is lowering the number of cosmetic and injectables procedures.
Product Type, Application, Route of Administration, Packaging Type, End User and Distribution Channel are the different segments in the global single programmable power supply market.
The top players Allergan, Galderma Laboratories, L.P., Fotona D.O.O, Merz Aesthetics, Bausch Health, Baxter International, Mentor Worldwide LLC, Croma Pharma International, Prollenium Medical Technologies Inc.
The products in Aesthetic Injectables are segmented into Hyaluronic acid and Biostimulator fillers.
LOOKING FOR COMPREHENSIVE MARKET KNOWLEDGE? ENGAGE OUR EXPERT SPECIALISTS.SPEAK TO AN ANALYST